Search
for
Sort by
Research 691–720 of 1000+
- Guidelines on the use of finasteride in androgenetic alopecia
- Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia
- Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
- The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
- Multifactorial Classification of Male and Female Androgenetic Alopecia
- Patient-Perceived Importance of Negative Effects of Androgenetic Alopecia in Women
- Serum Androgens and Genetic Linkage Analysis in Early Onset Androgenetic Alopecia
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- Androgenetic alopecia treated with topical minoxidil
- Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Development of a health-related quality of life questionnaire for women with androgenetic alopecia
- Quality of life assessment in patients with androgenetic alopecia
- Trichoscopic findings of androgenetic alopecia and their association with disease severity
- Scalp Dermatoscopic Findings in Androgenetic Alopecia and Their Relations with Disease Severity
- Elevated aldosterone levels in patients with androgenetic alopecia
- ANDROGENETIC ALOPECIA
- Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
- A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia
- A meta-analysis on evidence of platelet-rich plasma for androgenetic alopecia
- 5α-Reductase inhibitors in androgenetic alopecia
- Guidelines for management of androgenetic alopecia based on BASP classification-the Asian consensus committee guideline
- Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men
- Sex hormone-binding globulin and saliva testosterone levels in men with androgenetic alopecia
- Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia